Passifs Courants Changement Date
AbbVie USD 43.1B 1.46B 2026-09
Alaunos Therapeutics USD 864K 269K 2026-06
AstraZeneca USD 31.27B 286M 2026-09
Curis USD 14.97M 898K 2026-03
Cytokinetics USD 353.42M 171.99M 2026-09
Gilead Sciences USD 12B 982M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Laboratory Of America USD 2.82B 695M 2026-09
Novartis USD 32.52B 777M 2026-09
Pfizer USD 31.73B 920M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
TG Therapeutics USD 260.53M 7.97M 2026-09
Verastem USD 66.84M 5.42M 2026-03